Empower Advisory Group’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.92M Buy
138,631
+83,428
+151% +$4.53M 0.01% 189
2026
Q1
$3.46M Sell
55,203
-39,626
-42% -$3.17M 0.01% 191
2025
Q4
$9.04M Sell
94,829
-1,979
-2% -$194K 0.02% 173
2025
Q3
$9.45M Buy
96,808
+2,061
+2% +$213K 0.03% 169
2025
Q2
$10.2M Buy
94,747
+61,954
+189% +$6.27M 0.03% 161
2025
Q1
$3.31M Buy
32,793
+22,005
+204% +$2.22M 0.01% 185
2024
Q4
$964K Sell
10,788
-1,938
-15% -$171K ﹤0.01% 235
2024
Q3
$1.07M Sell
12,726
-395
-3% -$31.1K ﹤0.01% 231
2024
Q2
$1.01M Sell
13,121
-4
-0% -$293 ﹤0.01% 224
2024
Q1
$899K Buy
13,125
+332
+3% +$21.3K ﹤0.01% 236
2023
Q4
$740K Buy
12,793
+157
+1% +$8.38K ﹤0.01% 252
2023
Q3
$667K Buy
12,636
+328
+3% +$17.2K ﹤0.01% 266
2023
Q2
$666K Sell
12,308
-6
-0% -$313 ﹤0.01% 270
2023
Q1
$612K Buy
+12,314
New +$580K ﹤0.01% 283

Other funds holding BSX

Empower Advisory Group's BSX Position: Q2 2026 in Review

Empower Advisory Group increased its Boston Scientific (BSX) stake by 151% in Q2 2026, buying an estimated $4.53M and bringing the position to 138,631 shares worth $5.92M. The position accounts for 0.01% of the portfolio, ranked #189.

Empower Advisory Group first reported a position in BSX in Q1 2023 and has held it in 14 quarters since. The position peaked at $10.2M in Q2 2025. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Empower Advisory Group held 138,631 shares of Boston Scientific worth $5.92M as of Q2 2026.
  • Empower Advisory Group bought 83,428 Boston Scientific shares in Q2 2026, an estimated $4.53M.
  • Boston Scientific made up 0.01% of Empower Advisory Group's portfolio in Q2 2026, its #189 holding.
  • Empower Advisory Group first reported a position in Boston Scientific in Q1 2023 and has held it in 14 quarters since.
  • Empower Advisory Group's Boston Scientific position peaked at $10.2M in Q2 2025.
  • 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Empower Advisory Group's 13F filing for Q2 2026, filed 12 Aug 2026.